US Stock MarketDetailed Quotes

CNBX Pharmaceuticals (CNBX)

Watchlist
  • 0.0002
  • 0.00000.00%
15min DelayClose Jan 23 15:55 ET
174.15KMarket Cap0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNBX Pharmaceuticals (CNBX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2025
(FY)Aug 31, 2025
(Q4)Aug 31, 2025
(Q3)May 31, 2025
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.32%-47.41K
29.87%-171.31K
40.84%-28.55K
-23,219.56%-52.02K
58.47%-51.66K
45.61%-39.08K
-117.09%-244.27K
-335.17%-48.25K
101.21%225
-571.26%-124.4K
Net income from continuing operations
-231.04%-113.72K
54.84%-313.98K
-147.77%-150.11K
54.28%-59.73K
78.56%-69.79K
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
Operating gains losses
----
----
----
----
----
----
-96.74%88.93K
--0
----
----
Depreciation and amortization
--0
--0
--0
--0
--0
--0
-55.37%72.32K
--0
--0
-18.65%32.86K
Other non cash items
1,382.90%46.3K
137.01%39.81K
--18.33K
111.45%14.17K
-96.75%4.19K
-72.74%3.12K
-69.35%16.8K
--0
94.84%-123.71K
-94.62%129.06K
Change In working capital
355.07%20.02K
-22.75%102.86K
555.94%103.23K
-110.61%-6.46K
-81.20%13.93K
-137.74%-7.85K
-71.92%133.16K
-115.73%-22.64K
223.26%60.89K
-69.27%74.12K
-Change in receivables
---133
-98.17%1.64K
-0.73%1.64K
-99.99%16
99.97%-16
--0
747.72%89.64K
-99.21%1.65K
149.33%120.15K
-438.19%-57.49K
-Change in payables and accrued expense
356.76%20.15K
132.61%101.22K
518.16%101.59K
-160.59%-6.47K
-77.38%13.95K
-73.11%-7.85K
-91.08%43.51K
63.27%-24.29K
-96.49%10.69K
-45.74%61.66K
Cash from discontinued investing activities
Operating cash flow
-21.32%-47.41K
29.87%-171.31K
40.84%-28.55K
-23,219.56%-52.02K
58.47%-51.66K
45.61%-39.08K
-117.09%-244.27K
-335.17%-48.25K
101.21%225
-571.26%-124.4K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
0
359.38%113.48K
0
94.67K
-19.03%20K
Net PPE purchase and sale
--0
--0
--0
--0
--0
--0
--113.48K
--0
--94.67K
--20K
Net investment purchase and sale
----
----
----
----
----
----
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
359.38%113.48K
--0
--94.67K
-19.03%20K
Financing cash flow
Cash flow from continuing financing activities
33.33%40K
481.56%160K
2,281.59%30.01K
1,487.93%19.99K
80K
20.03%30K
-72.49%27.51K
-98.06%1.26K
-91.60%1.26K
0
Net issuance payments of debt
33.33%40K
481.56%160K
2,281.59%30.01K
1,487.93%19.99K
--80K
20.03%30K
-72.49%27.51K
-98.06%1.26K
-91.60%1.26K
--0
Cash from discontinued financing activities
Financing cash flow
33.33%40K
481.56%160K
2,281.59%30.01K
1,487.93%19.99K
--80K
20.03%30K
-72.49%27.51K
-98.06%1.26K
-91.60%1.26K
--0
Net cash flow
Beginning cash position
-42.80%15.11K
-79.63%26.42K
-81.41%13.65K
22.97%45.68K
-78.76%17.34K
-79.63%26.42K
10.37%129.7K
66.26%73.41K
-22.21%37.14K
278.00%81.65K
Current changes in cash
18.39%-7.41K
89.05%-11.31K
103.11%1.46K
-133.31%-32.03K
127.14%28.34K
81.11%-9.08K
-947.88%-103.28K
-154.93%-46.99K
2,773.26%96.16K
-499.26%-104.4K
Effect of exchange rate changes
----
----
----
----
----
----
----
----
---59.89K
----
End cash Position
-55.57%7.7K
-42.80%15.11K
-42.80%15.11K
-81.41%13.65K
22.97%45.68K
-78.76%17.34K
-79.63%26.42K
-79.63%26.42K
66.26%73.41K
-22.21%37.14K
Free cash flow
-21.32%-47.41K
30.21%-171.31K
40.84%-28.55K
-23,219.56%-52.02K
58.47%-51.66K
46.50%-39.08K
-118.15%-245.47K
-335.17%-48.25K
101.21%225
-571.26%-124.4K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2025(FY)Aug 31, 2025(Q4)Aug 31, 2025(Q3)May 31, 2025(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.32%-47.41K29.87%-171.31K40.84%-28.55K-23,219.56%-52.02K58.47%-51.66K45.61%-39.08K-117.09%-244.27K-335.17%-48.25K101.21%225-571.26%-124.4K
Net income from continuing operations -231.04%-113.72K54.84%-313.98K-147.77%-150.11K54.28%-59.73K78.56%-69.79K80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K
Operating gains losses -------------------------96.74%88.93K--0--------
Depreciation and amortization --0--0--0--0--0--0-55.37%72.32K--0--0-18.65%32.86K
Other non cash items 1,382.90%46.3K137.01%39.81K--18.33K111.45%14.17K-96.75%4.19K-72.74%3.12K-69.35%16.8K--094.84%-123.71K-94.62%129.06K
Change In working capital 355.07%20.02K-22.75%102.86K555.94%103.23K-110.61%-6.46K-81.20%13.93K-137.74%-7.85K-71.92%133.16K-115.73%-22.64K223.26%60.89K-69.27%74.12K
-Change in receivables ---133-98.17%1.64K-0.73%1.64K-99.99%1699.97%-16--0747.72%89.64K-99.21%1.65K149.33%120.15K-438.19%-57.49K
-Change in payables and accrued expense 356.76%20.15K132.61%101.22K518.16%101.59K-160.59%-6.47K-77.38%13.95K-73.11%-7.85K-91.08%43.51K63.27%-24.29K-96.49%10.69K-45.74%61.66K
Cash from discontinued investing activities
Operating cash flow -21.32%-47.41K29.87%-171.31K40.84%-28.55K-23,219.56%-52.02K58.47%-51.66K45.61%-39.08K-117.09%-244.27K-335.17%-48.25K101.21%225-571.26%-124.4K
Investing cash flow
Cash flow from continuing investing activities 000000359.38%113.48K094.67K-19.03%20K
Net PPE purchase and sale --0--0--0--0--0--0--113.48K--0--94.67K--20K
Net investment purchase and sale --------------------------0--0--------
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0359.38%113.48K--0--94.67K-19.03%20K
Financing cash flow
Cash flow from continuing financing activities 33.33%40K481.56%160K2,281.59%30.01K1,487.93%19.99K80K20.03%30K-72.49%27.51K-98.06%1.26K-91.60%1.26K0
Net issuance payments of debt 33.33%40K481.56%160K2,281.59%30.01K1,487.93%19.99K--80K20.03%30K-72.49%27.51K-98.06%1.26K-91.60%1.26K--0
Cash from discontinued financing activities
Financing cash flow 33.33%40K481.56%160K2,281.59%30.01K1,487.93%19.99K--80K20.03%30K-72.49%27.51K-98.06%1.26K-91.60%1.26K--0
Net cash flow
Beginning cash position -42.80%15.11K-79.63%26.42K-81.41%13.65K22.97%45.68K-78.76%17.34K-79.63%26.42K10.37%129.7K66.26%73.41K-22.21%37.14K278.00%81.65K
Current changes in cash 18.39%-7.41K89.05%-11.31K103.11%1.46K-133.31%-32.03K127.14%28.34K81.11%-9.08K-947.88%-103.28K-154.93%-46.99K2,773.26%96.16K-499.26%-104.4K
Effect of exchange rate changes -----------------------------------59.89K----
End cash Position -55.57%7.7K-42.80%15.11K-42.80%15.11K-81.41%13.65K22.97%45.68K-78.76%17.34K-79.63%26.42K-79.63%26.42K66.26%73.41K-22.21%37.14K
Free cash flow -21.32%-47.41K30.21%-171.31K40.84%-28.55K-23,219.56%-52.02K58.47%-51.66K46.50%-39.08K-118.15%-245.47K-335.17%-48.25K101.21%225-571.26%-124.4K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -